(Q46689230)

24 December 2017

title

An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia (English)

1 reference

24 December 2017

0 references

0 references

Serdar Dursun

1

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

24 December 2017

Journal of Psychopharmacology

published in

1 reference

24 December 2017

volume

19

1 reference

24 December 2017

issue

5 Suppl

1 reference

24 December 2017

page(s)

3-4

1 reference

24 December 2017

Remission in schizophrenia: proposed criteria and rationale for consensus

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057347

Risperidone long-acting injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057347

Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta) in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057347

Does risperidone have a place in the treatment of nonschizophrenic patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057347

Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057347

Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057347

21 January 2018

Identifiers

DOI

10.1177/0269881105057347

1 reference

24 December 2017

1 reference

24 December 2017